Additionally, with production of immunomodulatory IL-10, Th2-immunogloublin IgG4 class-switch recombination is favored over IgE, the former being far less potently tumoricidal, further attenuating anti-tumor responses. This evidence concerns the gene IGHE and neoplasm.